In the tumour microenvironment of human nasopharyngeal carcinoma, IL‐17A mediates AKT1 acetylation via p300, activating the Akt signalling pathway and stimulating the proliferation of nasopharyngeal carcinoma cells.53 The gene discussed is EP300; the disease is neoplasm.